TR200102019T2 - The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections. - Google Patents

The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections.

Info

Publication number
TR200102019T2
TR200102019T2 TR2001/02019T TR200102019T TR200102019T2 TR 200102019 T2 TR200102019 T2 TR 200102019T2 TR 2001/02019 T TR2001/02019 T TR 2001/02019T TR 200102019 T TR200102019 T TR 200102019T TR 200102019 T2 TR200102019 T2 TR 200102019T2
Authority
TR
Turkey
Prior art keywords
treatment
infections
hydroxylamic
isoxazolidinones
acids
Prior art date
Application number
TR2001/02019T
Other languages
Turkish (tr)
Inventor
Jomaa Hassan
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19903666A external-priority patent/DE19903666A1/en
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of TR200102019T2 publication Critical patent/TR200102019T2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Söz konusu bulus formül (I)'e uygun asgari bir tane terkibi ihtiva eden ilaçlar ve bunlarin insanlarda ve hayvanlarda bakteriler, mantarlar ve parazitlerin sebep oldugu enfeksiyonlarin tedavisi ve bu enfeksiyonlardan korunmak amaci ile kullanilmalarini kapsamaktadir.(Formül Var)The present invention includes drugs containing at least one composition according to formula (I) and their use for the treatment and protection of infections caused by bacteria, fungi and parasites in humans and animals (Formula Var).

TR2001/02019T 1999-01-13 2000-01-12 The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections. TR200102019T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900907 1999-01-13
DE19903666A DE19903666A1 (en) 1999-01-13 1999-01-30 Medicines containing 3-isoxazolidinones and hydroxylamic acids as an active ingredient and their use

Publications (1)

Publication Number Publication Date
TR200102019T2 true TR200102019T2 (en) 2002-04-22

Family

ID=26051290

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02019T TR200102019T2 (en) 1999-01-13 2000-01-12 The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections.

Country Status (14)

Country Link
EP (1) EP1143941A3 (en)
JP (1) JP2002534440A (en)
CN (1) CN1342078A (en)
AU (1) AU2436600A (en)
BR (1) BR0007491A (en)
CA (1) CA2360366A1 (en)
CZ (1) CZ20012380A3 (en)
HU (1) HUP0105412A2 (en)
IL (1) IL143795A0 (en)
NO (1) NO20013464L (en)
PL (1) PL350128A1 (en)
SK (1) SK9502001A3 (en)
TR (1) TR200102019T2 (en)
WO (1) WO2000041473A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
GB202209172D0 (en) * 2022-06-22 2022-08-10 Syngenta Crop Protection Ag Improvements in or relating to organic compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45174A (en) * 1973-08-10 1976-12-31 Merck & Co Inc Antibacterial compositions containing 3-fluoro-d-alanine type compound and n-substituted cycloserine compound
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
FR2290442A1 (en) * 1974-11-06 1976-06-04 Aries Robert Cycloserine-(hexahydro)rifamycin SV condensates - antibiotics, prepd from 3-formyl rifamycins and opt N-alkylated cycloserine
EP0219923B1 (en) * 1985-04-30 1992-09-02 Takeda Chemical Industries, Ltd. Antibiotic derivatives, their production and use
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
JPS63119476A (en) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd Isoxazolidone derivative
JPS63119462A (en) * 1986-11-05 1988-05-24 Takeda Chem Ind Ltd 5-membered-ring n-sulfo compound
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
DE69412469T2 (en) * 1993-03-16 1999-02-04 British Biotech Pharm HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS
WO1995006031A1 (en) * 1993-08-23 1995-03-02 Immunex Corporation Inhibitors of tnf-alpha secretion
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
WO1996013263A2 (en) * 1994-11-01 1996-05-09 Research Corporation Technologies, Inc. Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
US5919790A (en) * 1996-10-11 1999-07-06 Warner-Lambert Company Hydroxamate inhibitors of interleukin-1β converting enzyme
US6251913B1 (en) * 1997-03-28 2001-06-26 Zeneca Limited Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds

Also Published As

Publication number Publication date
SK9502001A3 (en) 2002-05-09
BR0007491A (en) 2001-11-20
EP1143941A3 (en) 2002-02-06
WO2000041473A3 (en) 2001-11-29
IL143795A0 (en) 2002-04-21
HUP0105412A2 (en) 2002-05-29
CN1342078A (en) 2002-03-27
CA2360366A1 (en) 2000-07-20
NO20013464L (en) 2001-09-12
PL350128A1 (en) 2002-11-04
AU2436600A (en) 2000-08-01
EP1143941A2 (en) 2001-10-17
NO20013464D0 (en) 2001-07-12
CZ20012380A3 (en) 2002-01-16
WO2000041473A2 (en) 2000-07-20
JP2002534440A (en) 2002-10-15

Similar Documents

Publication Publication Date Title
ATE303993T1 (en) 4-HYDROXYCHINOLINE-3-CARBOXAMIDE AND HYDRAZIDE AS ANTIVIRAL ACTIVES
PT1073470E (en) Pharmaceutical compositions containing active compounds capable of improving the absorption of active ingredients
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ES2172585T3 (en) DERIVED FROM BENZOIMIDAZOL.
TR200101499T1 (en) Azepinoindole derivatives, their preparation and uses.
YU48701A (en) Phenylphenanthridines with pde-iv inhibiting activity
ES2153975T3 (en) DERIVATIVES OF PIRIMIDONA WITH ANTIFUNGIC ACTIVITY.
TR200101124T2 (en) N- (2-aryl-propionyl) -sulphonamides and pharmaceutical preparations containing them.
TR200200883T2 (en) 2-substituted 1,1-biphenyl-2-carbonamides, manufacturing methods, use as drugs
AR014554A1 (en) POLYPEPTIDE COMPOUNDS, USEFUL FOR THE TREATMENT OF MICROBIAL INFECTIONS, PROCEDURE TO PREPARE THEM, COMPOSITIONS AND MEDICINES THAT INCLUDE AND THE USE OF SUCH COMPOUNDS AND METHOD FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIONS
TR200101649T2 (en) Piperazine derivatives.
BR0001201A (en) (Poly) thiaalkinoic compound, cosmetic composition, use of a cosmetic composition, use of a compound and pharmaceutical composition
TR200101979T2 (en) 5HT1 antagonists for antidepression treatment.
TR200101841T2 (en) The use of bisphosphonates to prevent infections and treat infections
DE50011645D1 (en) SPHINGOMYELINASE INHIBITORS AS ACTIVE AGENTS WITH ANTIAPOPTOTIC AND ANTISEPTIC EFFECT
TR200101832T2 (en) Organophosphorus compositions and their use.
TR200102019T2 (en) The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections.
FR2768145B1 (en) NOVEL COMPOUNDS DERIVED FROM DI- OR TRI-ACETIC ALKYLENE DIAMINE ACID, PROCESS FOR THEIR PREPARATION, THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS COMPRISING THE SAME
TR200003451T2 (en) Pyrimidine-Aminomethyl-Pyridine Derivatives, Their Preparation and Their Use in the Control of Helicobacter Bacteria
DE59403472D1 (en) MICROBICIDAL AGENTS
TR199901454T2 (en) Uses of aminoisothiazoles as germicides.
BR9808210A (en) Befenyloxazolines dissubstituted
TR200103212T2 (en) Ethers used as a fungicide
ATE241640T1 (en) FUSIDIC ACID DERIVATIVES
ES2069803T3 (en) USE OF PIRIDINARY SALTS FOR THE PROTECTION OF PLANTS AGAINST ATTACK BY MICROORGANISMS.